Written by Dan Cohen and Scott Matusow After consistent disappointments in the development of agents to treat metastatic triple-negative breast cancer (TNBC), novel …
Written by Dan Cohen and Scott Matusow These days, it seems as if every major pharmaceutical company is working on their own PD-1 targeted therapeutic regimen …
